Protection by 4th dose of BNT162b2 against Omicron in Israel

Yinon M. Bar-On, Yair Goldberg, Micha Mandel, Omri Bodenheimer, Ofra Amir, Laurence Freedman, Sharon Alroy-Preis, Nachman Ash, Amit Huppert, Ron Milo
doi: https://doi.org/10.1101/2022.02.01.22270232

Article usage

Article usage: February 2022 to May 2025

AbstractFullPdf
Feb 2022195654157930
Mar 20221634846612982
Apr 202270432557343
May 20221536711206
Jun 2022120367936
Jul 2022100991536
Aug 202280692301
Sep 202263374188
Oct 202253880207
Nov 2022426123160
Dec 202251399124
Jan 2023429117133
Feb 202338968107
Mar 202335869112
Apr 20232077397
May 20231836080
Jun 20232196294
Jul 202317871105
Aug 20232127587
Sep 20233157182
Oct 20233087370
Nov 20231696857
Dec 20231315158
Jan 20242064373
Feb 202415260132
Mar 20241725659
Apr 20241613074
May 20241562663
Jun 20242023382
Jul 20241722094
Aug 20241601696
Sep 202418416104
Oct 20241452760
Nov 20241511884
Dec 20241532467
Jan 20251541860
Feb 20251692959
Mar 202518127180
Apr 20251942483
May 202578939
Back to top
Posted February 01, 2022.
Download PDF
Data/Code
Email
Protection by 4th dose of BNT162b2 against Omicron in Israel
Yinon M. Bar-On, Yair Goldberg, Micha Mandel, Omri Bodenheimer, Ofra Amir, Laurence Freedman, Sharon Alroy-Preis, Nachman Ash, Amit Huppert, Ron Milo
medRxiv 2022.02.01.22270232; doi: https://doi.org/10.1101/2022.02.01.22270232
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area